Blum Robert I's Form 4 filing
Cytokinetics IncCYTK · filed Nov 18, 2026
- Accession no.
- 0001061983-26-000116
- Filed
- Nov 18, 2026, 7:12 PM ET
- Trade date
- Nov 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $401.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | MOption exerciseAcquired | +7,500 | $10.60 | +$79,500 | 286,044 | Direct | |
| Nov 16, 2026 | Common Stock | SSaleDisposed | −5,077 | $53.22F1 | −$270,197.94 | 280,967 | Direct | |
| Nov 16, 2026 | Common Stock | SSaleDisposed | −2,223 | $54.08F2 | −$120,219.84 | 278,744 | Direct | |
| Nov 16, 2026 | Common Stock | SSaleDisposed | −200 | $55.21F3 | −$11,042 | 278,544 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 126,745 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported transaction involves sale transactions from $52.80 to $53.80 per share. The weighted average price per share was $53.22. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
Referenced by the price of 1 transaction in Table I.
- F2
The reported transaction involves sale transactions from $53.80 to $54.46 per share. The weighted average price per share was $54.08. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
Referenced by the price of 1 transaction in Table I.
- F3
The reported transaction involves sale transactions from $54.94 to $55.59 per share. The weighted average price per share was $55.21. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
Referenced by the price of 1 transaction in Table I.